Biocartis

About:

Biocartis develops a diagnostics technology platform for the multiplexed detection of bio-analytes.

Website: http://www.biocartis.com

Twitter/X: biocartis_

Top Investors: Wellcome Trust, Philips, Debiopharm Group, Korys, Debiopharm Innovation Fund

Description:

Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexed detection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland.